R

Read Gene SA
WSE:RDG

Watchlist Manager
Read Gene SA
WSE:RDG
Watchlist
Price: 4.96 PLN -0.8% Market Closed
Market Cap: 58.5m PLN
Have any thoughts about
Read Gene SA?
Write Note

Balance Sheet

Balance Sheet Decomposition
Read Gene SA

Current Assets 5.2m
Cash & Short-Term Investments 4.4m
Receivables 773.5k
Other Current Assets 16.2k
Non-Current Assets 6.1m
Long-Term Investments 5k
PP&E 5.6m
Intangibles 42k
Other Non-Current Assets 500.9k
Current Liabilities 220.7k
Other Current Liabilities 220.7k
Non-Current Liabilities 9.6m
Other Non-Current Liabilities 9.6m

Balance Sheet
Read Gene SA

Rotate your device to view
Balance Sheet
Currency: PLN
Dec-2012 Dec-2013 Dec-2014 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
0
0
0
4
3
4
5
7
7
7
Cash
0
0
0
4
3
4
5
7
7
7
Cash Equivalents
0
0
0
0
0
0
0
0
0
0
Short-Term Investments
0
0
0
0
0
0
0
0
0
0
Total Receivables
0
0
0
2
2
2
1
1
1
2
Accounts Receivables
0
0
0
1
2
1
1
1
1
2
Other Receivables
0
0
0
1
1
0
0
0
0
0
Inventory
0
0
0
0
0
0
0
0
0
0
Other Current Assets
0
0
0
0
0
0
0
0
0
0
Total Current Assets
0
0
0
5
6
6
7
8
9
9
PP&E Net
9
9
0
8
8
8
7
7
6
6
PP&E Gross
9
0
0
0
0
0
0
0
0
0
Accumulated Depreciation
1
0
0
0
0
0
0
0
0
0
Intangible Assets
0
0
0
4
3
2
1
1
0
0
Long-Term Investments
0
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
1
1
0
1
1
0
0
0
0
0
Total Assets
11
N/A
10
-7%
0
N/A
18
N/A
17
-4%
16
-9%
15
-4%
16
+7%
15
-5%
16
+2%
Liabilities
Accounts Payable
1
0
0
1
1
0
1
1
1
1
Accrued Liabilities
1
1
4
1
6
6
6
0
0
0
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
1
0
0
Other Current Liabilities
0
0
0
0
1
0
0
0
0
0
Total Current Liabilities
1
1
4
3
8
7
7
2
1
1
Long-Term Debt
1
1
1
0
0
0
0
4
5
5
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
Other Liabilities
5
5
0
12
6
5
5
6
4
4
Total Liabilities
7
N/A
7
+1%
0
N/A
15
N/A
15
0%
13
-16%
12
-5%
12
+2%
10
-18%
10
+2%
Equity
Common Stock
1
1
0
1
1
1
1
1
1
1
Retained Earnings
3
2
0
2
2
3
3
3
5
5
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
4
N/A
3
-22%
0
N/A
3
N/A
2
-21%
3
+33%
3
+3%
4
+25%
5
+33%
6
+2%
Total Liabilities & Equity
11
N/A
10
-7%
0
N/A
18
N/A
17
-4%
16
-9%
15
-4%
16
+7%
15
-5%
16
+2%
Shares Outstanding
Common Shares Outstanding
12
12
0
12
12
12
12
12
12
12

See Also

Discover More